Basophil allergen threshold sensitivity, and peanut allergen components in relation to DBPCFC in children with suspected peanut allergy

Autor: Nilsson Caroline, Glaumann Susanne, Lilja Gunnar, Borres Magnus, Johansson SGO

Publikováno v: Clinical and Translational Allergy, Vol 1, Iss Suppl 1, p P66 (2011)

Externí odkaz: https://doaj.org/article/dd6901a72ea5409388907e24efc69e44

Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents.

Autor: Brandström J; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Vetander M; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden., Sundqvist AC; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden., Lilja G; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Johansson SGO; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Melén E; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Sverremark-Ekström E; Department of Molecular Biosciences, TheWenner-Gren Institute, Stockholm University, Stockholm, Sweden., Nopp A; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Nilsson C; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2019 Oct; Vol. 49 (10), pp. 1328-1341. Date of Electronic Publication: 2019 Aug 15.

Forthcoming articles.

Publikováno v: Clinical & Experimental Allergy. Nov1992, Vol. 22 Issue 11, p1039-1040. 2p.

The size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair) treatment.

Autor: Johansson SGO; Department of Medicine, Clinical Immunology and Allergy Unit, Karolinska Institute, Stockholm, Sweden.; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden., Nopp A; Department of Medicine, Clinical Immunology and Allergy Unit, Karolinska Institute, Stockholm, Sweden., Öman H; MIAB, Uppsala, Sweden., Ankerst J; Department of Medicine, University Hospital, Lund, Sweden., Cardell LO; Department of ENT, Karolinska University Hospital, Stockholm, Sweden., Grönneberg R; Department of Medicine, Asthma and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden., Matsols H; Department of Medicine, Asthma and Allergy Unit, Central Hospital, Falun, Sweden., Rudblad S; Department of ENT, University Hospital, Örebro, Sweden., Strand V; Division of Asthma and Allergy, St. Göran Hospital, Stockholm, Sweden., Stålenheim G; Department of Medicine, Asthma and Allergy Unit, University Hospital, Uppsala, Sweden.

Publikováno v: Allergy [Allergy] 2009 Oct; Vol. 64 (10), pp. 1472-1477. Date of Electronic Publication: 2009 Apr 14.

Basophil allergen threshold sensitivity to casein (casein‐specific CD‐sens) predicts allergic reactions at a milk challenge in most but not all patients.

Autor: Røisgård, Solveig¹ (AUTHOR), Nopp, Anna^2,3 (AUTHOR), Lindam, Anna⁴ (AUTHOR), Nilsson, Caroline A.^2,3 (AUTHOR), West, Christina E.¹ (AUTHOR) christina.west@umu.se

Publikováno v: Immunity, Inflammation & Disease. May2024, Vol. 12 Issue 5, p1-9. 9p.